A survey of Joint Commission accredited hospitals found that the majority had implemented safety planning at discharge for patients identified at risk for suicide, but few had included all key components of formal safety planning.
An FDA panel proposed revisions to premarket guidelines for evaluating pulse oximeter performance in order to eliminate racial bias and improve accuracy across various skin pigments.
Getinge is recalling the Cardiohelp Emergency Drive due to possible blocking or impairment of the emergency drive's cranking ability.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Read More
Philips Respironics says it plans to conduct additional testing on certain respiratory care and sleep devices involved in its June 2021 recall at the request of the FDA.
Read More
The FDA has requested Philips conduct additional testing on its recalled CPAP, BiPAP, and ventilator devices, calling testing to date inadequate to fully evaluate the risks posed to users.
Read More
Philips responded to recent media articles that claim the company knew about safety issues with certain CPAP machines and ventilators for years before recalling the devices in June 2021.
Read More
Hamilton Medical is recalling the Hamilton-C1, C2, C3, and T1 ventilators after receiving reports of software issues that may cause the ventilators to stop without notice.
Read More
The FDA has identified Draeger’s recall for its Carina sub-acute care ventilators as a Class I recall, the most serious type.
Read More
GE HealthCare’s Portrait Mobile platform enables real-time continuous monitoring with a personalized view of the patient’s vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit.
Read More
The recall was issued due to a misalignment of the check valve in the device’s manifold, which may cause the manifold to fail and interrupt therapy to neonates.
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
Read More
The recall is due to a container defect that may result in failure to deliver the recommended dose.
Read More
The company announced a voluntary field corrective action to address complaints of endobronchial combustion occurring when laser-compatible bronchoscopes are used during therapeutic procedures in combination with laser therapy equipment or argon plasma coagulation.
Read More
The American Academy of Pediatrics wants to improve patient safety for children who are directly hospitalized without going through the emergency department.
Read More